• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING Back to Search Results
Model Number 5200
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Information (3190)
Event Date 07/25/2014
Event Type  Injury  
Event Description
Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.In this case, it was reported that this bioprosthetic mitral annuloplasty ring was explanted due to dehiscence after an implant duration of nine (9) days.This was replaced with a 25 mm pericardial bioprosthesis.The patient was transferred to the intensive care unit in critical condition.
 
Manufacturer Narrative
(b)(4) = dehiscence.Method: device not returned.Additional manufacturer narrative the explanted device was not returned to edwards for analysis.Without return of the device, edwards is unable to confirm the clinical observation.Ring dehiscence, when detected early, is typically a result of an inadequate valve repair or prosthetic valve implantation in combination with friable myocardial tissue.Reoperations are primarily the result of a progression of disease, the patient's baseline hemodynamics, or technical failures and are not evidence of product malfunctions.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING
Type of Device
ANNULOPLASTY RING
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
one edwards way
irvine CA 92614
Manufacturer Contact
neil landry
1 edwards way
ms: lfs 33
irvine, CA 92614
9492502289
MDR Report Key4056824
MDR Text Key4807793
Report Number2015691-2014-02052
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K083470
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 08/05/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/12/2018
Device Model Number5200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/05/2014
Initial Date FDA Received09/03/2014
Date Device Manufactured11/21/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age55 YR
-
-